为您找到相关结果约22个

你是不是要搜索 期刊Lonsurf 点击跳转

Lonsurf (R) - A new Option for Patients with pretreated metastatic Gastric Cancer

Lonsurf (R) - A new Option for Patients with previously treated metastatic Gastric Cancer

Efficacy and safety of Trifluridin/Tipiracil (FTD/TPI) (Lonsurf (R)) in patients with metastatic colorectal

The European Commission has approved Servier for LONSURF® in combination with Bevacizumab in Female Patients

Sidedness and survival of chemo-refractory metastatic colorectal cancer treated with lonsurf or regorafenib

Lonsurf (trifluridine/tipiracil): assessing the impact of dose related toxicities and progression free

First real world oncology experiences with trifluridine/tipiracil (Lonsurf (R)) in Germany: results from

Long Term Real-World Outcomes of Trifluridine/Tipiracil in Metastatic Colorectal Cancer-A Single UK Centre Experience

TAS-102 has a tumoricidal activity in multiple myeloma

A bioequivalence study of trifluridine/tipiracil tablets in Chinese metastatic colorectal cancer patients under fed conditions

Metastatic Colorectal Cancer Management with trifluridine/tipiracil

Molecular modeling study of the thymidine phosphorylase inhibitor by SBDD and classical QSAR analysis

Radiosensitisation and enhanced tumour growth delay of colorectal cancer cells by sustained treatment with trifluridine/tipiracil and X-rays

Dihydropyrimidone Derivatives as Thymidine Phosphorylase Inhibitors: Inhibition Kinetics, Cytotoxicity, and Molecular Docking

Trifluridine/Tipiracil: A Review in Metastatic Gastric Cancer

为您找到相关结果约22个

共22条页码: 1/2页15条/页